These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 606612)
41. Advances and innovations in dialysis in the 21st century. Power A; Duncan N; Goodlad C Postgrad Med J; 2009 Feb; 85(1000):102-7. PubMed ID: 19329705 [TBL] [Abstract][Full Text] [Related]
42. [Peritoneal dialysis in the treatment of chronic renal failure]. Aranda Lara P; Martínez González JL; Juarez Fernández C Rev Clin Esp; 1978 Feb; 148(3):319-23. PubMed ID: 653051 [No Abstract] [Full Text] [Related]
43. [Tissue levels of fosfomycin and tobramycin in the rat kidney]. Savoia D; Fontana G; Di Carlo R G Ital Chemioter; 1976; 23(1):9-10. PubMed ID: 1029697 [No Abstract] [Full Text] [Related]
44. Dialysis therapy in children. Mehta KP J Indian Med Assoc; 2001 Jul; 99(7):368-73. PubMed ID: 11881847 [TBL] [Abstract][Full Text] [Related]
45. Proteomics in extracorporeal blood purification and peritoneal dialysis. Thongboonkerd V J Proteomics; 2010 Jan; 73(3):521-6. PubMed ID: 19527805 [TBL] [Abstract][Full Text] [Related]
46. [Development of peritoneal dialysis at Rijeka Clinical Hospital Center]. Zivcić-Cosić S; Vlahović A; Grzetić M; Matić-Glazar D Acta Med Croatica; 2004; 58(3):215-20. PubMed ID: 15503685 [TBL] [Abstract][Full Text] [Related]
47. Neurotransmitter imbalance in plasma and cerebrospinal fluid during dialytic treatment. Biasioli S; Chiaramonte S; Fabris A; Feriani M; Pisani E; Ronco C; Valli A; Dalla Fior T; D'Andrea G; La Greca G Trans Am Soc Artif Intern Organs; 1983; 29():44-9. PubMed ID: 6143435 [No Abstract] [Full Text] [Related]
49. [Different strategies of substitute treatment of end-stage chronic kidney failure by dialysis]. Viron B; Michel C; Mignon F Rev Prat; 1991 Apr; 41(12):1050-4. PubMed ID: 2052863 [TBL] [Abstract][Full Text] [Related]
50. [Administration of antibiotics to patients with acute and chronic renal insufficiency in oligoanuria]. Curelaru I Med Interna (Bucur); 1970 May; 22(5):567-72. PubMed ID: 5426382 [No Abstract] [Full Text] [Related]
52. Peritoneal dialysis in renal failure associated with spinal cord injury. Vaziri ND; Lopez G; Nikakhtar B; Gordon S; Penera N J Am Paraplegia Soc; 1984 Oct; 7(4):63-5. PubMed ID: 6512526 [TBL] [Abstract][Full Text] [Related]
53. Dialytic therapy in the management of chronic renal failure. Comty CM; Collins AJ Med Clin North Am; 1984 Mar; 68(2):399-425. PubMed ID: 6369031 [TBL] [Abstract][Full Text] [Related]
57. [Pharmacokinetics of ethambutol in healthy individuals and in patients with terminal renal failure]. Dume T; Wagner C; Wetzels E Dtsch Med Wochenschr; 1971 Sep; 96(36):1430-4. PubMed ID: 4998424 [No Abstract] [Full Text] [Related]
58. An Introduction to dialysis education: Issues, innovations and impact. Jaar BG; Choi MJ Semin Dial; 2018 Mar; 31(2):99-101. PubMed ID: 29509328 [No Abstract] [Full Text] [Related]
59. [Use of fosfomycin in antibiotic therapy. Its effectiveness in patients with acute renal insufficiency or on hemodialysis treatment]. Rossi R; Colantonio G; Fraticelli M; Giura C; Quarenghi MI; Polli O; Ferradini MA; Nonini MO G Ital Chemioter; 1979; 26(1-2):315-7. PubMed ID: 554823 [No Abstract] [Full Text] [Related]
60. Effect of protein and peptide fractions from the peritoneal dialysate of patients with chronic renal failure on the lipoprotein lipase activity. Lutz W Acta Med Pol; 1979; 20(2):131-41. PubMed ID: 532698 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]